Panelists explain the importance of quickly recognizing treatment-related adverse events associated with combined bevacizumab and olaparib to avoid treatment discontinuation or de-escalation.
Treatment of Emergent Adverse Events in Ovarian Cancer
Panelists explain the importance of quickly recognizing treatment-related adverse events associated with combined bevacizumab and olaparib to avoid treatment discontinuation or de-escalation.
0 Comments